For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $274.12 in the prior trading day, Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) closed at $274.41, up 0.11%. In other words, the price has increased by $0.11 from its previous closing price. On the day, 0.76 million shares were traded. MDGL stock price reached its highest trading level at $282.0505 during the session, while it also had its lowest trading level at $266.44.
Ratios:
Our goal is to gain a better understanding of MDGL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.93 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $382.
On April 22, 2024, BofA Securities started tracking the stock assigning a Underperform rating and target price of $150.BofA Securities initiated its Underperform rating on April 22, 2024, with a $150 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 03 ’24 when CRAVES FRED B sold 3,600 shares for $315.31 per share. The transaction valued at 1,135,122 led to the insider holds 11,000 shares of the business.
CRAVES FRED B sold 3,400 shares of MDGL for $1,191,028 on Nov 25 ’24. The Director now owns 14,600 shares after completing the transaction at $350.30 per share. On Nov 25 ’24, another insider, CRAVES FRED B, who serves as the Director of the company, bought 10,000 shares for $322.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDGL now has a Market Capitalization of 5984991744 and an Enterprise Value of 5105507840. For the stock, the TTM Price-to-Sale (P/S) ratio is 77.92 while its Price-to-Book (P/B) ratio in mrq is 7.70. Its current Enterprise Value per Revenue stands at 66.467 whereas that against EBITDA is -9.331.
Stock Price History:
Over the past 52 weeks, MDGL has reached a high of $368.29, while it has fallen to a 52-week low of $168.25. The 50-Day Moving Average of the stock is -13.66%, while the 200-Day Moving Average is calculated to be 5.19%.
Shares Statistics:
The stock has traded on average 440.78K shares per day over the past 3-months and 381740 shares per day over the last 10 days, according to various share statistics. A total of 21.81M shares are outstanding, with a floating share count of 18.39M. Insiders hold about 15.70% of the company’s shares, while institutions hold 104.31% stake in the company. Shares short for MDGL as of 1735603200 were 4106529 with a Short Ratio of 9.32, compared to 1732838400 on 4281332. Therefore, it implies a Short% of Shares Outstanding of 4106529 and a Short% of Float of 27.02.
